Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: A prospective, randomized controlled trial

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Bispectral index monitoring (BIS) is a quantitative assessment of brain cortical activity. The aim of this study was to determine if BIS-guided nurse-administered propofol sedation would decrease by ≥20% both recovery time and propofol dose compared to standard propofol sedation for endoscopic ultrasound (EUS). Prospectively, eligible outpatients were randomized to BIS-guided or standard propofol sedation during EUS. Propofol was given by nurses in intermittent boluses with sedation targeted at a BIS score of <65-75. For the control group, the nurse was blinded to BIS scores and sedation was titrated to a modified observer's assessment of alertness/sedation scale (MOAA/S) score ≤3. Of 50 patients enrolled, data for 44 randomized to BIS-guidance (n = 24) and the control group (n = 20) were evaluated. Between the BIS-guided and control group there was no difference between the mean procedure duration, total propofol dose, recovery time, mean intraoperative MOAA/S, and mean BIS score. Compared to standard propofol sedation for EUS, BIS-guided propofol sedation offers no significant decrease in postprocedure recovery times or propofol doses.

Original languageEnglish
Pages (from-to)2739-2745
Number of pages7
JournalDigestive Diseases and Sciences
Volume53
Issue number10
DOIs
StatePublished - Oct 2008

Fingerprint

Propofol
Randomized Controlled Trials
Nurses
Control Groups
Outpatients
Brain

Keywords

  • Endoscopic ultrasound
  • Monitoring
  • Propofol
  • Sedation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{387373e06df74fd3b638ab7f5fed36e8,
title = "Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: A prospective, randomized controlled trial",
abstract = "Bispectral index monitoring (BIS) is a quantitative assessment of brain cortical activity. The aim of this study was to determine if BIS-guided nurse-administered propofol sedation would decrease by ≥20{\%} both recovery time and propofol dose compared to standard propofol sedation for endoscopic ultrasound (EUS). Prospectively, eligible outpatients were randomized to BIS-guided or standard propofol sedation during EUS. Propofol was given by nurses in intermittent boluses with sedation targeted at a BIS score of <65-75. For the control group, the nurse was blinded to BIS scores and sedation was titrated to a modified observer's assessment of alertness/sedation scale (MOAA/S) score ≤3. Of 50 patients enrolled, data for 44 randomized to BIS-guidance (n = 24) and the control group (n = 20) were evaluated. Between the BIS-guided and control group there was no difference between the mean procedure duration, total propofol dose, recovery time, mean intraoperative MOAA/S, and mean BIS score. Compared to standard propofol sedation for EUS, BIS-guided propofol sedation offers no significant decrease in postprocedure recovery times or propofol doses.",
keywords = "Endoscopic ultrasound, Monitoring, Propofol, Sedation",
author = "John DeWitt",
year = "2008",
month = "10",
doi = "10.1007/s10620-008-0198-x",
language = "English",
volume = "53",
pages = "2739--2745",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound

T2 - A prospective, randomized controlled trial

AU - DeWitt, John

PY - 2008/10

Y1 - 2008/10

N2 - Bispectral index monitoring (BIS) is a quantitative assessment of brain cortical activity. The aim of this study was to determine if BIS-guided nurse-administered propofol sedation would decrease by ≥20% both recovery time and propofol dose compared to standard propofol sedation for endoscopic ultrasound (EUS). Prospectively, eligible outpatients were randomized to BIS-guided or standard propofol sedation during EUS. Propofol was given by nurses in intermittent boluses with sedation targeted at a BIS score of <65-75. For the control group, the nurse was blinded to BIS scores and sedation was titrated to a modified observer's assessment of alertness/sedation scale (MOAA/S) score ≤3. Of 50 patients enrolled, data for 44 randomized to BIS-guidance (n = 24) and the control group (n = 20) were evaluated. Between the BIS-guided and control group there was no difference between the mean procedure duration, total propofol dose, recovery time, mean intraoperative MOAA/S, and mean BIS score. Compared to standard propofol sedation for EUS, BIS-guided propofol sedation offers no significant decrease in postprocedure recovery times or propofol doses.

AB - Bispectral index monitoring (BIS) is a quantitative assessment of brain cortical activity. The aim of this study was to determine if BIS-guided nurse-administered propofol sedation would decrease by ≥20% both recovery time and propofol dose compared to standard propofol sedation for endoscopic ultrasound (EUS). Prospectively, eligible outpatients were randomized to BIS-guided or standard propofol sedation during EUS. Propofol was given by nurses in intermittent boluses with sedation targeted at a BIS score of <65-75. For the control group, the nurse was blinded to BIS scores and sedation was titrated to a modified observer's assessment of alertness/sedation scale (MOAA/S) score ≤3. Of 50 patients enrolled, data for 44 randomized to BIS-guidance (n = 24) and the control group (n = 20) were evaluated. Between the BIS-guided and control group there was no difference between the mean procedure duration, total propofol dose, recovery time, mean intraoperative MOAA/S, and mean BIS score. Compared to standard propofol sedation for EUS, BIS-guided propofol sedation offers no significant decrease in postprocedure recovery times or propofol doses.

KW - Endoscopic ultrasound

KW - Monitoring

KW - Propofol

KW - Sedation

UR - http://www.scopus.com/inward/record.url?scp=50949123189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949123189&partnerID=8YFLogxK

U2 - 10.1007/s10620-008-0198-x

DO - 10.1007/s10620-008-0198-x

M3 - Article

C2 - 18274899

AN - SCOPUS:50949123189

VL - 53

SP - 2739

EP - 2745

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -